Phase II trial of sorafenib (bay 43-9006) in patients with advanced anaplastic carcinoma of the thyroid (ATC)

Authors
Category Primary study
Year 2009
This article has no abstract
Epistemonikos ID: 2499ce5c3264fb8ed89330113606a500c477d84e
First added on: Jul 22, 2020